12:00 AM
Mar 19, 2012
 |  BC Week In Review  |  Company News  |  Deals

Alkermes, Elan deal

Elan raised $52.8 million through the sale 3.2 million Alkermes shares at $16.50 to cover the overallotment from its March 8 divestiture, bringing the...

Read the full 96 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >